Vogt-Koyanagi-Harada with Unilateral Clinical Presentation: A Case Report
Purpose: To report a case of acute Vogt-Koyanagi-Harada (VKH) disease with unilateral clinical manifestations followed by late fellow eye involvement.
Case Report: This case report reviews the 12-month follow-up observation of a 44-year old woman who presented to the emergency department with unilateral progressive and painless visual blurring. Ophthalmoscopic findings, best-corrected visual acuity (BCVA), fluorescein angiography (FAG), enhanced-depth optical coherence tomography (EDIOCT), indocyanine green angiography, and response to treatment were evaluated. Her BCVA was 20/50 (logMAR: 0.4) in the right eye and 20/20 (logMAR: 0) in the left eye. Eye examination revealed optic disc swelling and multiple serous retinal detachments in the right eye and a normal left eye. She had headache, dysacusia, and mild hearing problems. Her past ocular and drug histories were unremarkable. Retinal imaging revealed characteristic features of VKH in the right eye. All laboratory testing results were inconclusive. VA and OCT findings significantly improved following the treatment with methylprednisolone 1 g/day continued by tapering dose of oral prednisolone. Two months after the presentation and during prednisolone tapering, VA of the left eye decreased and fundus examination revealed multiple serous retinal detachments in this eye.
Conclusion: Ophthalmologists should recognize unilateral and asymmetrical VKH disease with subtle systemic involvement.
Asymmetric VKH, Enhanced-Depth Optical Coherence Tomography, Indocyanine Green Angiography, Vogt-Koyanagi-Harada Disease (VKH)
1. Rao NA, Gupta A, Dustin L, Chee SP, Okada AA, Khairallah M, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology 2010;117:591–599.e1.
2. Herbort CP, Mochizuki M. Vogt–Koyanagi–Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan. Int Ophthalmol 2007;27:67–79.
3. Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol 2007;27:87–95.
4. Rao NA. Pathology of Vogt–Koyanagi–Harada disease. Int Ophthalmol 2007;27:81–85.
5. Snyder DA, Tessler HH. Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 1980;90:69–75.
6. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647–652.
7. Lavezzo MM, Sakata VM, Morita C, Rodriguez EEC, Abdallah SF, da Silva FT, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis 2016;11:29.
8. Sakata VM, Da Silva FT, Hirata CE, Marin MLC, Rodrigues H, Kalil J, et al. High rate of clinical recurrence in patients with Vogt–Koyanagi–Harada disease treated with early high-dose corticosteroids. Graef Arch Clin Exp Ophthalmol 2015;253:785–790.
9. Usui Y, Goto H, Sakai J-I, Takeuchi M, Usui M, Rao NA. Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases. Graef Arch Clin Exp Ophthalmol 2009;247:1127–1132.
10. Neves A, Cardoso A, Almeida M, Campos J, Campos A, Sousa JPC. Unilateral Vogt-Koyanagi-Harada disease: a clinical case report. Case Rep Ophthalmol 2015;6:361–365.
11. Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, et al. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 2012;53:4668–4675.
12. Cunningham ET, Jr, Rathinam SR, Tugal-Tutkun I, Muccioli C, Zierhut M. Vogt-koyanagi-Harada disease. Taylor & Francis; 2014.
13. Forster DJ, Green RL, Rao NA. Unilateral manifestation of the Vogt-Koyanagi-Harada syndrome in a 7-year-old child. Am J Ophthalmol 1991;111:380–382.